✦ LIBER ✦

Foamy virus as a gene transfer vector to the central nervous system

✍ Scribed by Caprariello, A V; Miller, R H; Selkirk, S M

Book ID: 109855111
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 322 KB
Volume: 16
Category: Article
ISSN: 0969-7128
DOI: 10.1038/gt.2008.171

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adenoviral vectors: prospects for gene d

Adenoviral vectors: prospects for gene delivery to the central nervous system

✍ Parks, Robin J; Bramson, Jonathan L 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 26 KB

A model system for in vivo gene transfer

A model system for in vivo gene transfer into the central nervous system using an adenoviral vector

✍ Davidson, Beverly L.; Allen, Edward D.; Kozarsky, Karen F.; Wilson, James M.; Ro 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 604 KB

Stable gene transfer to the nervous syst

Stable gene transfer to the nervous system using a non-primate lentiviral vector

✍ Mitrophanous, K A; Yoon, S; Rohll, J B; Patil, D; Wilkes, F J; Kim, V N; Kingsma 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 305 KB

Growth factor enhanced retroviral gene t

Growth factor enhanced retroviral gene transfer to the adult central nervous system

✍ King, L A; Mitrophanous, K A; Clark, L A; Kim, V N; Rohll, J B; Kingsman, A J; C 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 395 KB

Direct in vivo gene transfer to ependyma

Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors

✍ Bajocchi, Gianluigi; Feldman, Sanford H.; Crystal, Ronald G.; Mastrangeli, Andre 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 796 KB

Recombinant AAV-mediated gene delivery t

Recombinant AAV-mediated gene delivery to the central nervous system

✍ L. Tenenbaum; A. Chtarto; E. Lehtonen; T. Velu; J. Brotchi; M. Levivier 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 1 views

Various regions of the brain have been successfully transduced by recombinant adeno-associated virus (rAAV) vectors with no detected toxicity. When using the cytomegalovirus immediate early (CMV) promoter, a gradual decline in the number of transduced cells has been described. In contrast, the use o